If you are age 19-50 and have genital herpes (HSV-2) and have had it for at least 1 year and have had anywhere from 3-9 outbreaks in the past year, then you may qualify to participate in a clinical research study testing the safety and effectiveness of an investigational vaccine for the treatment of genital herpes. Call 205-996-4099 or visit www.uab.edu/avrc. Compensation is provided for those who enroll.